tiprankstipranks
Trending News
More News >
Baird Medical Investment Holdings (BDMD)
NASDAQ:BDMD
US Market

Baird Medical Investment Holdings (BDMD) Ratios

Compare
47 Followers

Baird Medical Investment Holdings Ratios

BDMD's free cash flow for Q2 2025 was $―. For the 2025 fiscal year, BDMD's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.77 1.77 2.11 2.11 2.29
Quick Ratio
1.74 1.74 2.05 2.03 1.98
Cash Ratio
0.09 0.09 0.08 0.11 0.31
Solvency Ratio
0.36 0.37 0.57 0.83 1.27
Operating Cash Flow Ratio
-0.18 -0.18 -0.05 0.03 0.54
Short-Term Operating Cash Flow Coverage
-0.37 -0.37 -0.12 0.08 2.58
Net Current Asset Value
$ 23.21M$ 23.21M$ 19.08M$ 16.92M$ 12.14M
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.27 0.20 0.17 0.11
Debt-to-Equity Ratio
0.53 0.53 0.32 0.29 0.56
Debt-to-Capital Ratio
0.34 0.34 0.24 0.22 0.36
Long-Term Debt-to-Capital Ratio
0.08 0.08 0.00 0.00 0.00
Financial Leverage Ratio
1.97 1.97 1.59 1.64 5.02
Debt Service Coverage Ratio
0.85 0.83 1.32 1.95 5.92
Interest Coverage Ratio
26.57 26.55 41.50 45.55 77.42
Debt to Market Cap
0.40 0.11 0.10 0.10 0.03
Interest Debt Per Share
0.99 0.84 1.56 1.23 0.43
Net Debt to EBITDA
1.09 1.11 0.78 0.40 >-0.01
Profitability Margins
Gross Profit Margin
88.16%88.16%86.56%79.90%83.61%
EBIT Margin
41.35%39.59%37.71%42.24%46.03%
EBITDA Margin
44.43%43.66%40.86%41.30%55.59%
Operating Profit Margin
41.35%41.35%37.71%38.85%42.99%
Pretax Profit Margin
38.04%38.04%39.29%41.38%45.47%
Net Profit Margin
33.62%33.62%33.52%35.82%42.12%
Continuous Operations Profit Margin
34.01%34.01%33.88%36.41%36.73%
Net Income Per EBT
88.40%88.40%85.33%86.55%92.63%
EBT Per EBIT
91.98%91.98%104.19%106.53%105.78%
Return on Assets (ROA)
15.97%15.97%18.60%29.49%44.70%
Return on Equity (ROE)
31.56%31.40%29.50%48.47%224.40%
Return on Capital Employed (ROCE)
35.34%35.34%31.44%51.26%72.86%
Return on Invested Capital (ROIC)
22.59%22.59%21.66%36.10%51.21%
Return on Tangible Assets
15.99%15.99%18.62%29.57%44.92%
Earnings Yield
40.99%6.41%12.98%19.49%16.48%
Efficiency Ratios
Receivables Turnover
0.80 0.80 1.00 1.42 2.23
Payables Turnover
3.50 3.50 7.68 32.68 13.36
Inventory Turnover
3.38 3.38 3.70 5.45 1.49
Fixed Asset Turnover
4.86 4.86 4.49 12.86 8.34
Asset Turnover
0.48 0.48 0.55 0.82 1.06
Working Capital Turnover Ratio
1.44 1.55 1.62 2.31 3.37
Cash Conversion Cycle
462.69 462.69 416.57 313.32 382.01
Days of Sales Outstanding
459.03 459.03 365.42 257.58 163.89
Days of Inventory Outstanding
107.97 107.97 98.65 66.91 245.44
Days of Payables Outstanding
104.31 104.31 47.50 11.17 27.33
Operating Cycle
567.00 567.00 464.08 324.49 409.33
Cash Flow Ratios
Operating Cash Flow Per Share
-0.29 -0.25 -0.13 0.08 0.73
Free Cash Flow Per Share
-0.42 -0.36 -0.48 -0.87 0.54
CapEx Per Share
0.13 0.11 0.35 0.95 0.19
Free Cash Flow to Operating Cash Flow
1.45 1.45 3.59 -11.25 0.74
Dividend Paid and CapEx Coverage Ratio
-2.21 -2.21 -0.39 0.08 0.77
Capital Expenditure Coverage Ratio
-2.21 -2.21 -0.39 0.08 3.79
Operating Cash Flow Coverage Ratio
-0.30 -0.30 -0.09 0.07 1.79
Operating Cash Flow to Sales Ratio
-0.17 -0.17 -0.03 0.01 0.19
Free Cash Flow Yield
-17.83%-4.72%-4.50%-8.48%5.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
2.46 15.60 7.70 5.13 6.07
Price-to-Sales (P/S) Ratio
1.40 5.24 2.58 1.84 2.56
Price-to-Book (P/B) Ratio
0.77 4.90 2.27 2.49 13.62
Price-to-Free Cash Flow (P/FCF) Ratio
-5.65 -21.19 -22.20 -11.80 18.32
Price-to-Operating Cash Flow Ratio
-4.85 -30.76 -79.63 132.72 13.49
Price-to-Earnings Growth (PEG) Ratio
0.02 0.80 >-0.01 -0.03 0.00
Price-to-Fair Value
0.77 4.90 2.27 2.49 13.62
Enterprise Value Multiple
4.24 13.12 7.10 4.85 4.59
Enterprise Value
69.32M 212.13M 91.22M 70.23M 70.77M
EV to EBITDA
4.21 13.12 7.10 4.85 4.59
EV to Sales
1.87 5.73 2.90 2.00 2.55
EV to Free Cash Flow
-7.56 -23.14 -24.94 -12.84 18.30
EV to Operating Cash Flow
-10.98 -33.60 -89.44 144.51 13.47
Tangible Book Value Per Share
1.83 1.55 4.70 4.08 2.19
Shareholders’ Equity Per Share
1.83 1.55 4.71 4.13 0.72
Tax and Other Ratios
Effective Tax Rate
0.11 0.11 0.14 0.12 0.19
Revenue Per Share
1.71 1.45 4.15 5.58 3.86
Net Income Per Share
0.57 0.49 1.39 2.00 1.62
Tax Burden
0.88 0.88 0.85 0.87 0.93
Interest Burden
0.92 0.96 1.04 0.98 0.99
Research & Development to Revenue
0.17 0.17 0.14 0.11 0.04
SG&A to Revenue
0.19 0.16 0.27 0.20 0.24
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-0.51 -0.50 -0.10 0.04 0.52
Currency in USD